[1]
Sharma, V., Chawla, S., Garg, S. and Singh, B. 2024. Efficacy and Safety of Vildagliptin and Remogliflozin as Add-On Therapy to Metformin in Patients of Type 2 Diabetes Mellitus: An open-label comparative study. Sultan Qaboos University Medical Journal. 1, 1 (Jan. 2024). DOI:https://doi.org/10.18295/squmj.1.2024.006.